Skip to the page

Data / Medical devices / Canada / GeneOhm Sciences Canada, ULC.

GeneOhm Sciences Canada, ULC.: FDA-registered device maker in Quebec, Canada, 22 510(k) clearances and 1 PMA approval

GeneOhm Sciences Canada, ULC. is registered with the FDA (registration 3007420875) in Quebec, Canada. It lists 19 device types. The FDA files 22 510(k) clearances and 1 PMA approval under its listings, the newest dated October 31, 2025. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3007420875
Address
2555 Boul. du Parc-Technologique, Quebec, Canada, G1P 4S5
Owner or operator
Becton Dickinson and Company (9922032)
Roles
Manufacturer
First device listed
December 23, 2004
Registered through
2027
Brand names listed
659611_BD Horizon™ Brilliant Stain Buffer, BD Alcohol Blend Rinse, BD BBL™ Agar, Grade A, BD BBL™ BCYE Agar Base, BD BBL™ BiGGY Agar, BD BBL™ Bile Esculin Agar, BD BBL™ Blood Agar Base Infusion Agar, BD BBL™ Bovine Albumin (Fraction V) and more

Devices it lists

DeviceProduct codeClassRoleSource
C. Difficile Toxin Gene Amplification AssayOZN2Manufactureraccessdata.fda.gov
Clinical Sample ConcentratorJJH1Manufactureraccessdata.fda.gov
Dna Probe, Nucleic Acid Amplification, ChlamydiaMKZ1Manufactureraccessdata.fda.gov
Dna-Reagents, NeisseriaLSL2Manufactureraccessdata.fda.gov
Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay SystemPCI2Manufactureraccessdata.fda.gov
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay SystemPCH2Manufactureraccessdata.fda.gov
General Purpose ReagentPPM1Manufactureraccessdata.fda.gov
Instrumentation For Clinical Multiplex Test SystemsNSU2Manufactureraccessdata.fda.gov
Kit, Dna Detection, Human PapillomavirusMAQ3Manufactureraccessdata.fda.gov
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial AgentsQOF2Manufactureraccessdata.fda.gov
Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen TestNJR1Manufactureraccessdata.fda.gov
Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted InfectionsQEP2Manufactureraccessdata.fda.gov
Reagents, 2019-Novel Coronavirus Nucleic AcidQJRNManufactureraccessdata.fda.gov
Real Time Nucleic Acid Amplification SystemOOI2Manufactureraccessdata.fda.gov
Respiratory Specimen Nucleic Acid Sars-Cov-2 TestQQX2Manufactureraccessdata.fda.gov
System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct SpecimenPOC2Manufactureraccessdata.fda.gov
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct SpecimenNQX2Manufactureraccessdata.fda.gov
Trichomonas Vaginalis Nucleic Acid Amplification Test SystemOUY2Manufactureraccessdata.fda.gov
Vaginitis And Bacterial Vaginosis Nucleic Acid Detection SystemPQA2Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
October 31, 2025K250358BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR SystemPCISubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
April 22, 2025K243343BD CTGCTV2QEPSubstantially EquivalentBd Integrated Diagnostic Solutions/Becton,accessdata.fda.gov
July 31, 2023K230956BD Respiratory Viral Panel for BD MAX™ System; BD Respiratory Viral Panel-SCV2 for BD MAX™ SystemQOFSubstantially EquivalentBd Integrated Diagnostic Solutions /accessdata.fda.gov
March 6, 2023K223653BD Vaginal PanelPQASubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
September 21, 2022K220607BD MAX Enteric Viral PanelPCHSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
August 19, 2022K220193BD MAX Enteric Parasite PanelPCHSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
July 28, 2022K214122BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial PanelPCISubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
May 10, 2022K210585BD CTGCTV2QEPSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
October 18, 2021K201017BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitPQASubstantially EquivalentGeneohm Sciences Canada, Inc. (Bd Life Sciences)accessdata.fda.gov
October 21, 2019K191957BD MAX Vaginal PanelPQASubstantially EquivalentGeneohm Sciences Canada, Inc. (Bd Diagnostics)accessdata.fda.gov
August 29, 2019K190613BD MAX Check-Points CPOPOCSubstantially EquivalentCheck-Points Health B.V.accessdata.fda.gov
January 8, 2019K182692BD MAX CTGCTV2, BD MAX SystemOUYSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
November 29, 2018K181427BD MAX Enteric Viral Panel, BD MAX InstrumentPCHSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
May 2, 2017K170308BD MAX Extended Enteric Bacterial Panel, BD MAX SystemPCHSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
October 28, 2016DEN160001BD MAX Vaginal Panel, BD MAX InstrumentPQAUnknownGeneohm Sciences Canada, Inc. (Bd Diagnostics)accessdata.fda.gov
August 25, 2015K143648BD MAX Enteric Parasite Panel, BD MAX InstrumentPCHSubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
May 6, 2014K140111BD MAX(TM) ENTERIC BACTERIAL PANEL;BD MAX(TM) INSTRUMENTPCISubstantially EquivalentBecton, Dickinson and Companyaccessdata.fda.gov
December 20, 2013K133605BD MAX MRSA XT, BD MAX INSTRUMENTNQXSubstantially EquivalentGeneohm Sciences Canada, Inc.accessdata.fda.gov
November 26, 2013K132822BD MAX STAPHSR ASSAY, INSTRUMENTNQXSubstantially EquivalentGeneohm Sciences Canada, Inc. (Bd Diagnostics)accessdata.fda.gov
April 2, 2013K130470BD MAX CDIFF ASSAY, BD MAX INSTRUMENTOZNSubstantially EquivalentGeneohm Sciences Canada, Inc. (Bd Diagnostics)accessdata.fda.gov
February 16, 2012K111860BD MAX GBS ASSAY, BD MAX INSTRUMENTNJRSubstantially EquivalentBecton, Dickinson & COaccessdata.fda.gov
December 11, 2008K081825BD PROBETEC NEISSERIA GONORRHOEAE (GC) Q AMPLIFIED DNA ASSAYLSLSubstantially EquivalentBecton, Dickinson & COaccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
February 12, 2018P160037BD ONCLARITY HPV ASSAYMAQ28August 19, 2026accessdata.fda.gov

Compare with other makers

Updated August 19, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.